BackgroundThere is widespread evidence that statistical methods play an important role in original research articles, especially in medical research. The evaluation of statistical methods and reporting in journals suffers from a lack of standardized methods for assessing the use of statistics. The objective of this study was to develop and evaluate an instrument to assess the statistical intensity in research articles in a standardized way.MethodsA checklist-type measure scale was developed by selecting and refining items from previous reports about the statistical contents of medical journal articles and from published guidelines for statistical reporting. A total of 840 original medical research articles that were published between 2007–2015 in 16 journals were evaluated to test the scoring instrument. The total sum of all items was used to assess the intensity between sub-fields and journals. Inter-rater agreement was examined using a random sample of 40 articles. Four raters read and evaluated the selected articles using the developed instrument.ResultsThe scale consisted of 66 items. The total summary score adequately discriminated between research articles according to their study design characteristics. The new instrument could also discriminate between journals according to their statistical intensity. The inter-observer agreement measured by the ICC was 0.88 between all four raters. Individual item analysis showed very high agreement between the rater pairs, the percentage agreement ranged from 91.7% to 95.2%.ConclusionsA reliable and applicable instrument for evaluating the statistical intensity in research papers was developed. It is a helpful tool for comparing the statistical intensity between sub-fields and journals. The novel instrument may be applied in manuscript peer review to identify papers in need of additional statistical review.

Objectives: Demonstrate the application of decision trees—classification and regression trees (CARTs), and their cousins, boosted regression trees (BRTs)—to understand structure in missing data. Setting: Data taken from employees at 3 different industrial sites in Australia. Participants: 7915 observations were included. Materials and methods: The approach was evaluated using an occupational health data set comprising results of questionnaires, medical tests and environmental monitoring. Statistical methods included standard statistical tests and the ‘rpart’ and ‘gbm’ packages for CART and BRT analyses, respectively, from the statistical software ‘R’. A simulation study was conducted to explore the capability of decision tree models in describing data with missingness artificially introduced. Results: CART and BRT models were effective in highlighting a missingness structure in the data, related to the type of data (medical or environmental), the site in which it was collected, the number of visits, and the presence of extreme values. The simulation study revealed that CART models were able to identify variables and values responsible for inducing missingness. There was greater variation in variable importance for unstructured as compared to structured missingness. Discussion: Both CART and BRT models were effective in describing structural missingness in data. CART models may be preferred over BRT models for exploratory analysis of missing data, and selecting variables important for predicting missingness. BRT models can show how values of other variables influence missingness, which may prove useful for researchers. Conclusions: Researchers are encouraged to use CART and BRT models to explore and understand missing data.

Introduction

Medical Technology and Innovation Statistics: In recent years, there has been a remarkable acceleration in the pace of medical technology advancements. These are driven by factors such as technological advancements, increased funding for research and development, and the growing demand for innovative solutions to address healthcare challenges.

These advancements have the potential to revolutionize various aspects of healthcare delivery, from diagnostics and treatment to patient monitoring and disease prevention.

Health Service Research (HSR) PubMed Queries contains preformulated specialized PubMed searches on healthcare quality and costs.

About OPCRD

Optimum Patient Care Research Database (OPCRD) is a real-world, longitudinal, research database that provides anonymised data to support scientific, medical, public health and exploratory research. OPCRD is established, funded and maintained by Optimum Patient Care Limited (OPC) – which is a not-for-profit social enterprise that has been providing quality improvement programmes and research support services to general practices across the UK since 2005.

Key Features of OPCRD

OPCRD has been purposefully designed to facilitate real-world data collection and address the growing demand for observational and pragmatic medical research, both in the UK and internationally. Data held in OPCRD is representative of routine clinical care and thus enables the study of ‘real-world’ effectiveness and health care utilisation patterns for chronic health conditions.

OPCRD unique qualities which set it apart from other research data resources: • De-identified electronic medical records of more than 24.9 million patients • OPCRD covers all major UK primary care clinical systems • OPCRD covers approximately 35% of the UK population • One of the biggest primary care research networks in the world, with over 1,175 practices • Linked patient reported outcomes for over 68,000 patients including Covid-19 patient reported data • Linkage to secondary care data sources including Hospital Episode Statistics (HES)

Data Available in OPCRD

OPCRD has received data contributions from over 1,175 practices and currently holds de-identified research ready data for over 24.9 million patients or data subjects. This includes longitudinal primary care patient data and any data relevant to the management of patients in primary care, and thus covers all conditions. The data is derived from both electronic health records (EHR) data and patient reported data from patient questionnaires delivered as part of quality improvement. OPCRD currently holds over 68,000 patient reported questionnaire data on Covid-19, asthma, COPD and rare diseases.

Approvals and Governance

OPCRD has NHS research ethics committee (REC) approval to provide anonymised data for scientific and medical research since 2010, with its most recent approval in 2020 (NHS HRA REC ref: 20/EM/0148). OPCRD is governed by the Anonymised Data Ethics and Protocols Transparency committee (ADEPT). All research conducted using anonymised data from OPCRD must gain prior approval from ADEPT. Proceeds from OPCRD data access fees and detailed feasibility assessments are re-invested into OPC services for the continued free provision of patient quality improvement programmes for contributing practices and patients.

For more information on OPCRD please visit: https://opcrd.co.uk/

Abstract

A UK Primary Care Database

Documentation

IMRD, incorporating THIN, a Cegedim Database in electronic form, and otherwise, is a longitudinal patient database. Primary care practices in the UK are recruited by Cegedim to participate in the data collection scheme. The data collection software removes practice, practitioner and patient identifiers at source, retaining information on patient’s, (1) the physical health or condition of that patient, (2) the mental health or condition of that patient, (3) the diagnosis of the condition of that patient, (4) the care or treatment given to that patient, and (5) other information which is to an extent derived, directly or indirectly, from such information.

Data provided by: IQVIA

Section 2

Section 3

The basic purpose of the Health Interview Survey is to obtain information about the amount and distribution of illness, its effects in terms of disability and chronic impairments, and the kinds of health services people receive. There are five types of records in this core survey, each in a separate data file. The variables in the Household File (Part 1) include type of living quarters, size of family, number of families in household, and geographic region. The variables in the Person File (Part 2) include sex, age, race, marital status, veteran status, education, income, industry and occupation codes, and limits on activity. These variables are found in the Condition, Doctor Visit, and Hospital Episode Files as well. The Person File also supplies data on height, weight, bed days, doctor visits, hospital stays, years at residence, and region variables. The Condition (Part 3), Doctor Visit (Part 4), and Hospital Episode (Part 5) Files contain information on each reported condition, two-week doctor visit, or hospitalization (twelve-month recall), respectively. A sixth, seventh, eighth, and ninth file have been added, along with the five core files. The Alcohol/Health Practices Supplement File (Part 6) includes information on diet, smoking and drinking habits, and health problems. The Bed Days and Dental Care Supplement File (Part 7) contains information on the number of bed days, the number of and reason for dental visits, treatment(s) received, type of dentist seen, and travel time for visit. The Doctor Services Supplement File (Part 8) supplies data on visits to doctors or other health professionals, reasons for visits, health conditions, and operations performed. The Health Insurance Supplement File (Part 9) documents basic demographic information along with medical coverage and health insurance plans, as well as differentiates between hospital, doctor visit, and surgical insurance coverage.

The Public Health Research Database (PHRD) is a linked asset which currently includes Census 2011 data; Mortality Data; Hospital Episode Statistics (HES); GP Extraction Service (GPES) Data for Pandemic Planning and Research data. Researchers may apply for these datasets individually or any combination of the current 4 datasets.

The purpose of this dataset is to enable analysis of deaths involving COVID-19 by multiple factors such as ethnicity, religion, disability and known comorbidities as well as age, sex, socioeconomic and marital status at subnational levels. 2011 Census data for usual residents of England and Wales, who were not known to have died by 1 January 2020, linked to death registrations for deaths registered between 1 January 2020 and 8 March 2021 on NHS number. The data exclude individuals who entered the UK in the year before the Census took place (due to their high propensity to have left the UK prior to the study period), and those over 100 years of age at the time of the Census, even if their death was not linked. The dataset contains all individuals who died (any cause) during the study period, and a 5% simple random sample of those still alive at the end of the study period. For usual residents of England, the dataset also contains comorbidity flags derived from linked Hospital Episode Statistics data from April 2017 to December 2019 and GP Extraction Service Data from 2015-2019.

Big Data Analytics for Clinical Research Market Outlook

As per our latest research, the Big Data Analytics for Clinical Research market size reached USD 7.45 billion globally in 2024, reflecting a robust adoption pace driven by the increasing digitization of healthcare and clinical trial processes. The market is forecasted to grow at a CAGR of 17.2% from 2025 to 2033, reaching an estimated USD 25.54 billion by 2033. This significant growth is primarily attributed to the rising need for real-time data-driven decision-making, the proliferation of electronic health records (EHRs), and the growing emphasis on precision medicine and personalized healthcare solutions. The industry is experiencing rapid technological advancements, making big data analytics a cornerstone in transforming clinical research methodologies and outcomes.

Several key growth factors are propelling the expansion of the Big Data Analytics for Clinical Research market. One of the primary drivers is the exponential increase in clinical data volumes from diverse sources, including EHRs, wearable devices, genomics, and imaging. Healthcare providers and research organizations are leveraging big data analytics to extract actionable insights from these massive datasets, accelerating drug discovery, optimizing clinical trial design, and improving patient outcomes. The integration of artificial intelligence (AI) and machine learning (ML) algorithms with big data platforms has further enhanced the ability to identify patterns, predict patient responses, and streamline the entire research process. These technological advancements are reducing the time and cost associated with clinical research, making it more efficient and effective.

Another significant factor fueling market growth is the increasing collaboration between pharmaceutical & biotechnology companies and technology firms. These partnerships are fostering the development of advanced analytics solutions tailored specifically for clinical research applications. The demand for real-world evidence (RWE) and real-time patient monitoring is rising, particularly in the context of post-market surveillance and regulatory compliance. Big data analytics is enabling stakeholders to gain deeper insights into patient populations, treatment efficacy, and adverse event patterns, thereby supporting evidence-based decision-making. Furthermore, the shift towards decentralized and virtual clinical trials is creating new opportunities for leveraging big data to monitor patient engagement, adherence, and safety remotely.

The regulatory landscape is also evolving to accommodate the growing use of big data analytics in clinical research. Regulatory agencies such as the FDA and EMA are increasingly recognizing the value of data-driven approaches for enhancing the reliability and transparency of clinical trials. This has led to the establishment of guidelines and frameworks that encourage the adoption of big data technologies while ensuring data privacy and security. However, the implementation of stringent data protection regulations, such as GDPR and HIPAA, poses challenges related to data integration, interoperability, and compliance. Despite these challenges, the overall outlook for the Big Data Analytics for Clinical Research market remains highly positive, with sustained investments in digital health infrastructure and analytics capabilities.

From a regional perspective, North America currently dominates the Big Data Analytics for Clinical Research market, accounting for the largest share due to its advanced healthcare infrastructure, high adoption of digital technologies, and strong presence of leading pharmaceutical companies. Europe follows closely, driven by increasing government initiatives to promote health data interoperability and research collaborations. The Asia Pacific region is emerging as a high-growth market, supported by expanding healthcare IT investments, rising clinical trial activities, and growing awareness of data-driven healthcare solutions. Latin America and the Middle East & Africa are also witnessing gradual adoption, albeit at a slower pace, due to infrastructural and regulatory challenges. Overall, the global market is poised for substantial growth across all major regions over the forecast period.

In 2024, a total of 184 clinical trials started in Mexico, down from 267 reported a year earlier. 2020 was the year with the highest clinical studies opened in the North American country. As of 2024, Latin America and Africa concentrated only one percent of the pharmaceutical research and development companies worldwide.

The Journal of Community Health Management FAQ - ResearchHelpDesk - The Journal of Community Health Management (JCHM) is open access, double-blind peer-review journal publishing quarterly since 2014. JCHM is proclaimed by Innovative Education and Scientific Research Foundation, print and published by Innovative Publication. It has an International Standard Serial Number (ISSN 2394-272X, e ISSN 2394-2738). JCHM permits authors to self-archive final approval of the articles on any OAI-compliant institutional/subject-based repository. Aim and Scope JCHM is focusing on Community Health which is the branch of the Public Health, it's making people aware and describing their role as determinants of their own and other people’s health in contrast to environmental health which focal point on the physical environment and its impact on people health. It concentrates on the maintenance, protection, and improvement of the health status of population groups and communities. The scope is, therefore, huge covering almost all streams of Community Health Management starting from original research articles, review articles, short communications, and clinical cases as well as studies covering clinical, experimental and applied topics on Community health Management on above subjective areas. The scope of the journal isn't restricted to those subjects however it's the broader coverage of all the newest updates and specialties. Indexing The Journal is an index with Index Copernicus (Poland), Google Scholar, J-gate, EBSCO (USA) database, Academia.edu, CrossRef, ROAD, InfoBase Index, GENAMIC, etc. Keywords Acute Care, Bio-statics, Community Health, Epidemiology and Health Services Research, Health Management, Medicine and Allied branches of Medical Sciences including Health Statistics, Nutrition, Preventive Medicine, Primary Prevention, Primary Health Care, Secondary Prevention, Secondary Healthcare, Tertiary Healthcare.

Financial overview and grant giving statistics of Mann Medical Research Organization

Big Data Analytics In Healthcare Market size is estimated at USD 37.22 Billion in 2024 and is projected to reach USD 74.82 Billion by 2032, growing at a CAGR of 9.12% from 2026 to 2032.

Big Data Analytics In Healthcare Market: Definition/ Overview

Big Data Analytics in Healthcare, often referred to as health analytics, is the process of collecting, analyzing, and interpreting large volumes of complex health-related data to derive meaningful insights that can enhance healthcare delivery and decision-making. This field encompasses various data types, including electronic health records (EHRs), genomic data, and real-time patient information, allowing healthcare providers to identify patterns, predict outcomes, and improve patient care.

Distribution of workers by selected characteristics.

NCHS has linked data from various surveys with Medicare program enrollment and health care utilization and expenditure data from the Centers for Medicare & Medicaid Services (CMS). Linkage of the NCHS survey participants with the CMS Medicare data provides the opportunity to study changes in health status, health care utilization and costs, and prescription drug use among Medicare enrollees. Medicare is the federal health insurance program for people who are 65 or older, certain younger people with disabilities, and people with End-Stage Renal Disease.

Each of the 21 data collections on this CD-ROM is located in a separate directory named for the collection's ICPSR study number. The Health and Medical Care Archive is the newest of the topical archives at ICPSR. As of 1996, it contained over four dozen research data collections focused on medical care, its delivery, and health conditions primarily (but not exclusively) in the United States. The holdings in this archive encompass empirical data on health and health care collected initially by health care researchers in universities as well as in public and private agencies, with the aid of grants from the Robert Wood Johnson Foundation.

Restricted Data Files Available at the Data Centers Researchers and users with approved research projects can access restricted data files that have not been publicly released for reasons of confidentiality at the AHRQ Data Center in Rockville, Maryland. Qualified researchers can also access restricted data files through the U.S. Census Research Data Center (RDC) network (http://www.census.gov/ces/dataproducts/index.html -- Scroll down the page and click on the Agency for Health Care Research and Quality (AHRQ) link.) For information on the RDC research proposal process and the data sets available, read AHRQ-Census Bureau agreement on access to restricted MEPS data.

About this dataset

Context

The dataset tabulates the population of Medical Lake by gender across 18 age groups. It lists the male and female population in each age group along with the gender ratio for Medical Lake. The dataset can be utilized to understand the population distribution of Medical Lake by gender and age. For example, using this dataset, we can identify the largest age group for both Men and Women in Medical Lake. Additionally, it can be used to see how the gender ratio changes from birth to senior most age group and male to female ratio across each age group for Medical Lake.

Key observations

Largest age group (population): Male # 30-34 years (355) | Female # 35-39 years (308). Source: U.S. Census Bureau American Community Survey (ACS) 2019-2023 5-Year Estimates.

Content

When available, the data consists of estimates from the U.S. Census Bureau American Community Survey (ACS) 2019-2023 5-Year Estimates.

Age groups:

• Under 5 years
• 5 to 9 years
• 10 to 14 years
• 15 to 19 years
• 20 to 24 years
• 25 to 29 years
• 30 to 34 years
• 35 to 39 years
• 40 to 44 years
• 45 to 49 years
• 50 to 54 years
• 55 to 59 years
• 60 to 64 years
• 65 to 69 years
• 70 to 74 years
• 75 to 79 years
• 80 to 84 years
• 85 years and over

Scope of gender :

Please note that American Community Survey asks a question about the respondents current sex, but not about gender, sexual orientation, or sex at birth. The question is intended to capture data for biological sex, not gender. Respondents are supposed to respond with the answer as either of Male or Female. Our research and this dataset mirrors the data reported as Male and Female for gender distribution analysis.

Variables / Data Columns

• Age Group: This column displays the age group for the Medical Lake population analysis. Total expected values are 18 and are define above in the age groups section.
• Population (Male): The male population in the Medical Lake is shown in the following column.
• Population (Female): The female population in the Medical Lake is shown in the following column.
• Gender Ratio: Also known as the sex ratio, this column displays the number of males per 100 females in Medical Lake for each age group.

Good to know

Margin of Error

Data in the dataset are based on the estimates and are subject to sampling variability and thus a margin of error. Neilsberg Research recommends using caution when presening these estimates in your research.

Custom data

If you do need custom data for any of your research project, report or presentation, you can contact our research staff at research@neilsberg.com for a feasibility of a custom tabulation on a fee-for-service basis.

Inspiration

Neilsberg Research Team curates, analyze and publishes demographics and economic data from a variety of public and proprietary sources, each of which often includes multiple surveys and programs. The large majority of Neilsberg Research aggregated datasets and insights is made available for free download at https://www.neilsberg.com/research/.

Recommended for further research

This dataset is a part of the main dataset for Medical Lake Population by Gender. You can refer the same here

Health Data Archiving Market size is expected to be worth around USD 3.4 Billion by 2033 from USD 1.4 Billion in 2023